天力鋰能(301152.SZ):簽署合計2.286億元重大合同
格隆匯11月30日丨天力鋰能(301152.SZ)公佈,近期,新鄉天力鋰能股份有限公司及全資子公司四川天力鋰能有限公司(簡稱“四川天力”)與湖南榮融智能科技有限公司分別簽署了《天力鋰能三元正極材料建設項目及智能自動化控制生產線總包合同》(簡稱“合同1”)、《四川天力鋰能有限公司年產兩萬噸磷酸鐵鋰項目及智能自動化化控制生產線總包合同》(簡稱“合同2”)。合同1金額約人民幣1.01億元(含税)。合同2金額約人民幣1.276億元(含税)。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.